Skip to content

Clinical trials

Completed Phase 2 Neuroectodermal Tumors, Primitive, Peripheral trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroectodermal Tumors, Primitive, Peripheral Phase: Phase 2 Status: Completed Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20023
20032
20043
20052
20064
20072
20083
20101
20111
20121
20131
20161
20174
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)17
Memorial Sloan Kettering Cancer Center8
Children's Oncology Group6
City of Hope Medical Center2
Children's Cancer and Leukaemia Group1
Columbia University1
Daiichi Sankyo1
Dana-Farber Cancer Institute1
Eastern Cooperative Oncology Group1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroectodermal Tumors, Primitive, Peripheral43
Sarcoma34
Osteosarcoma25
Neuroblastoma15
Rhabdomyosarcoma13
Central Nervous System Neoplasms10
Wilms Tumor10
Desmoplastic Small Round Cell Tumor9
Medulloblastoma9
Hepatoblastoma8

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.